Raphaël Metrop, PharmD
Raphaël Metrop, PharmD, is a Partner in the Alira Health Transaction Advisory Division, leading clients on M&A, licensing, capital raise, and strategic partnership projects.
Before joining Alira Health in October 2018, Raphaël was Head of Corporate Business Development of Fab’entech, and founder of a small consulting company providing services to a French family office. Raphaël’s experience includes international corporate and business development, mainly in the startup environment. He was the Corporate Business Development Manager of Imaxio, now known as Osivax, where he worked on a range of projects in immunology, including acquisition and divestment operations, in- and out-licensing deals, submission of grant applications, creation of public-private consortiums, management of R&D programs, and monitoring of patent portfolios.
Raphaël holds a Pharmaceutical Doctorate from the University of Lyon, France, and a master’s degree in Marketing and Management from the IMIS Institute, France. He also has an International Certificate in Corporate Finance from HEC Paris, France.
Highlights
Key areas of expertise
- Corporate Development
- Business Development
- R&D start-ups
- Biotechnology
- Immunology
- Rare Diseases
Languages spoken
English
French
Spanish